نتایج جستجو برای: bupropion

تعداد نتایج: 1673  

2009
Young-Min Park Heon-Jeong Lee Seung-Gul Kang Jae-Hyuck Cho Leen Kim

Bupropion is a selective norepinephrine and dopamine reuptake inhibitor with no serotonergic activity, and is therefore an antidepressant with unique pharmacological properties. There are some reports that selective serotonin reuptake inhibitors (SSRIs) or mirtazapine can induce adverse effects including restless legs syndrome (RLS) and that bupropion can reverse these adverse effects. Here, we...

Journal: :Antimicrobial agents and chemotherapy 2008
Evan D Kharasch Darain Mitchell Rebecka Coles Roberto Blanco

Ritonavir is the most potent and efficacious inhibitor of cytochrome P4503A (CYP3A), and it is used accordingly for the pharmacoenhancement of other antiretrovirals. Paradoxically, ritonavir induces the clinical metabolism and clearance of many drugs. The mechanism by which ritonavir inhibits and induces clinical drug metabolism is unknown. Ritonavir induces CYP2B6 in human hepatocytes. This in...

Journal: :Archivos de bronconeumologia 2001
Dorota Górecka

BACKGROUND Tobacco smoking is associated with chronic obstructive pulmonary disease (COPD) in more than 80% of cases. Our aim was to investigate the effect of sustained-release bupropion (amfebutamone) (SR) in promoting abstinence from smoking in patients with COPD. METHODS In a double-blind, randomised, placebo-controlled trial 404 individuals with mild or moderate COPD who smoked 15 or more...

Journal: :PloS one 2016
Andrea E Steuer Corina Schmidhauser Eva H Tingelhoff Yasmin Schmid Anna Rickli Thomas Kraemer Matthias E Liechti

3,4-methylenedioxymethamphetamine (MDMA; ecstasy) metabolism is known to be stereoselective, with preference for S-stereoisomers. Its major metabolic step involves CYP2D6-catalyzed demethylenation to 3,4-dihydroxymethamphetamine (DHMA), followed by methylation and conjugation. Alterations in CYP2D6 genotype and/or phenotype have been associated with higher toxicity. Therefore, the impact of CYP...

Journal: :Experimental and clinical psychopharmacology 2010
Doug Hyun Han Jun Won Hwang Perry F Renshaw

Bupropion has been used in the treatment of patients with substance dependence based on its weak inhibition of dopamine and norepinephrine reuptake. We hypothesized that 6 weeks of bupropion sustained release (SR) treatment would decrease craving for Internet game play as well as video game cue-induced brain activity in patients with Internet video game addiction (IAG). Eleven subjects who met ...

Journal: :The Medical journal of Australia 2003
Corrine R Balit Christa N Lynch Geoffrey K Isbister

OBJECTIVE To investigate the toxicity of bupropion hydrochloride in deliberate self-poisoning in adults and accidental ingestion by children. DESIGN AND SETTING Prospective study of cases identified from calls to the New South Wales Poisons Information Centre (NSW PIC), with follow-up through hospital medical records. PARTICIPANTS Patients with bupropion poisoning managed in hospital, about...

Journal: :Acta medica Iranica 2014
Mehdi Hamedi Mohammadreza Mohammdi Ali Ghaleiha Zahra Keshavarzi Morteza Jafarnia Rasool Keramatfar Rosa Alikhani Abolfazl Ehyaii Shahin Akhondzadeh

Attention-Deficit/Hyperactivity Disorder is one of the most common mental disorders in childhood, and it continues to adulthood without proper treatment. Stimulants have been used in the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) for many years, and the efficacy of methylphenidate in the treatment of adults with ADHD has been proven to be acceptable according to meta-analysis ...

2008

Smoking is the greatest single preventable cause of death in Ireland • All six Nicotine Replacement Therapy (NRT) products and bupropion are available on GMS. Choice should be made on the smokers personal preference, tolerance for side effects for each product and dependence on nicotine • Combination NRT may be more effective than using single products. NRT is not contraindicated in patients wi...

2010

In March 2010, Orexigen(R) Therapeutics submitted a new drug application (NDA) for approval of naltrexone sustained release (SR)/bupropion SR (Contrave(R)) for the treatment of obesity in the US. The tablet contains naltrexone SR 32 mg and bupropion SR 360 mg. The drug has been tested in four randomized, double-blind, placebo-controlled, phase III trials and the co-primary endpoints were met in...

2002
DENNIS K. MILLER SANGEETHA P. SUMITHRAN LINDA P. DWOSKIN

Bupropion, an efficacious antidepressant and smoking cessation agent, inhibits dopamine and norepinephrine transporters (DAT and NET, respectively). Recently, bupropion has been reported to noncompetitively inhibit 3 2, 3 4, and 4 2 nicotinic acetylcholine receptors (nAChRs) expressed in Xenopus oocytes or established cell lines. The present study evaluated bupropion-induced inhibition of nativ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید